{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:00:00Z","timestamp":1790265600919,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05951-0","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:55:59Z","timestamp":1790218559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of edaravone dexborneol in acute ischemic stroke patients undergoing endovascular thrombectomy: a systematic review and meta-analysis"],"prefix":"10.1007","author":[{"given":"Bilal Wazir","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Haneef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchu Srujan","family":"Nagarakanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Huzaifa","family":"Khattak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Mustafa","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayyaba Ikram","family":"Qazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Alejandro Rivas","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ali","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneeq Mahmood","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Faaz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haris Wazir","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Yahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atta Ur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad Ghanim","family":"Al-Badri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Muneeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"8","key":"5951_CR1","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1056\/NEJMoa1713973","volume":"378","author":"GW Albers","year":"2018","unstructured":"Albers GW, Marks MP, Kemp S et al (2018) Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 378(8):708\u2013718","journal-title":"N Engl J Med"},{"issue":"7","key":"5951_CR2","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/j.1476-5381.2009.00196.x","volume":"157","author":"PMW Bath","year":"2009","unstructured":"Bath PMW, Gray LJ, Bath AJG et al (2009) Effects of NXY-059 in experimental stroke: an individual animal meta-analysis. Br J Pharmacol 157(7):1157\u20131171","journal-title":"Br J Pharmacol"},{"issue":"1","key":"5951_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41572-019-0118-8","volume":"5","author":"BCV Campbell","year":"2019","unstructured":"Campbell BCV, De Silva DA, Macleod MR et al (2019) Ischaemic stroke. Nat Rev Dis Primers 5(1):70","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"5951_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1474-4422(14)70054-7","volume":"13","author":"A Chamorro","year":"2014","unstructured":"Chamorro A, Amaro S, Castellanos M et al (2014) Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b\/3 trial. Lancet Neurol 13(5):453\u2013460","journal-title":"Lancet Neurol"},{"issue":"8","key":"5951_CR5","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S1474-4422(16)00114-9","volume":"15","author":"\u00c1 Chamorro","year":"2016","unstructured":"Chamorro \u00c1, Dirnagl U, Urra X et al (2016) Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol 15(8):869\u2013881","journal-title":"Lancet Neurol"},{"issue":"1","key":"5951_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12883-024-03712-1","volume":"24","author":"W Chen","year":"2024","unstructured":"Chen W, Zhang H, Li Z et al (2024) Effects of edaravone dexborneol on functional outcome and inflammatory response in patients with acute ischemic stroke. BMC Neurol 24(1):209","journal-title":"BMC Neurol"},{"issue":"1","key":"5951_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57774-x","volume":"16","author":"HS Chen","year":"2025","unstructured":"Chen HS, Zhao ZA, Shen XY et al (2025) Edaravone dexborneol for ischemic stroke with sufficient recanalization after thrombectomy: a randomized phase II trial. Nat Commun 16(1):2393","journal-title":"Nat Commun"},{"issue":"12","key":"5951_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2025.108505","volume":"34","author":"X Chen","year":"2025","unstructured":"Chen X, Wang L, Xiong Y et al (2025) Efficacy and safety of edaravone dexborneol in acute large vessel occlusion patients with successful recanalization after endovascular treatment. J Stroke Cerebrovasc Dis 34(12):108505","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"5951_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u2013188","journal-title":"Control Clin Trials"},{"issue":"10","key":"5951_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","volume":"23","author":"VL Feigin","year":"2024","unstructured":"Feigin VL, Abate MD, Abate YH et al (2024) Global, regional, and national burden of stroke and its risk factors, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 23(10):973\u20131003","journal-title":"Lancet Neurol"},{"key":"5951_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2022.107299","volume":"219","author":"M Fidalgo","year":"2022","unstructured":"Fidalgo M, Ricardo Pires J, Viseu I et al (2022) Edaravone for acute ischemic stroke: systematic review with meta-analysis. Clin Neurol Neurosurg 219:107299","journal-title":"Clin Neurol Neurosurg"},{"issue":"9","key":"5951_CR12","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick PB, Scuteri A, Black SE et al (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 42(9):2672\u20132713","journal-title":"Stroke"},{"issue":"10029","key":"5951_CR13","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal M, Menon BK, van Zwam WH et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387(10029):1723\u20131731","journal-title":"Lancet"},{"issue":"9302","key":"5951_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0140-6736(02)07451-2","volume":"359","author":"DA Grimes","year":"2002","unstructured":"Grimes DA, Schulz KF (2002) Bias and causal associations in observational research. Lancet 359(9302):248\u2013252","journal-title":"Lancet"},{"issue":"13","key":"5951_CR15","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke W, Kaste M, Bluhmki E et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317\u20131329","journal-title":"N Engl J Med"},{"issue":"4","key":"5951_CR16","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1161\/01.STR.0000012515.66889.24","volume":"33","author":"GJ Hankey","year":"2002","unstructured":"Hankey GJ, Jamrozik K, Broadhurst RJ et al (2002) Long-term disability after first-ever stroke and related prognostic factors in the Perth Community Stroke Study, 1989\u20131990. Stroke 33(4):1034\u20131040","journal-title":"Stroke"},{"key":"5951_CR17","unstructured":"Higgins JPT, Thomas J, Chandler J et al (eds.) (n.d.) Cochrane handbook for systematic reviews of interventions. Available at: https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current.\u00a0Accessed 29 March 2026"},{"issue":"7414","key":"5951_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560","journal-title":"BMJ"},{"issue":"10227","key":"5951_CR19","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0140-6736(20)30258-0","volume":"395","author":"MD Hill","year":"2020","unstructured":"Hill MD, Goyal M, Menon BK et al (2020) Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. Lancet 395(10227):878\u2013887","journal-title":"Lancet"},{"issue":"1","key":"5951_CR20","doi-asserted-by":"publisher","DOI":"10.1515\/tnsci-2022-0312","volume":"14","author":"X Hu","year":"2023","unstructured":"Hu X, Qian Z, Chen J et al (2023) Effects of edaravone dexborneol on neurological function and serum inflammatory factor levels in patients with acute anterior circulation large vessel occlusion stroke. Transl Neurosci 14(1):20220312","journal-title":"Transl Neurosci"},{"issue":"8","key":"5951_CR21","doi-asserted-by":"publisher","first-page":"9569","DOI":"10.1007\/s00210-025-03950-1","volume":"398","author":"M Kashbour","year":"2025","unstructured":"Kashbour M, Shata A, Wagdy M et al (2025) Efficacy and safety of edaravone dexborneol in acute ischemic stroke: systematic review and meta-analysis of randomized controlled trials. Naunyn Schmiedebergs Arch Pharmacol 398(8):9569\u20139582","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"8","key":"5951_CR22","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S1474-4422(12)70104-7","volume":"11","author":"RF Keep","year":"2012","unstructured":"Keep RF, Hua Y, Xi G (2012) Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol 11(8):720\u2013731","journal-title":"Lancet Neurol"},{"key":"5951_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1349369","volume":"15","author":"Y Liang","year":"2024","unstructured":"Liang Y, Yu Y, Liu J et al (2024) Blood-brain barrier disruption and hemorrhagic transformation in acute stroke before endovascular reperfusion therapy. Front Neurol 15:1349369","journal-title":"Front Neurol"},{"issue":"4","key":"5951_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000047109","volume":"105","author":"J Luo","year":"2026","unstructured":"Luo J, Jia W, Wan M et al (2026) Effect of edaravone dexborneol on clinical outcomes in patients with acute posterior circulation ischemic stroke undergoing endovascular therapy: a retrospective single-center study. Medicine (Baltimore) 105(4):e47109","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"5951_CR25","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213949","volume":"105","author":"G Ma","year":"2025","unstructured":"Ma G, Mo R, Yao X et al (2025) Clinical and safety outcomes of edaravone dexborneol in acute ischemic stroke: a multicenter, prospective, cohort study. Neurology 105(4):e213949","journal-title":"Neurology"},{"key":"5951_CR26","doi-asserted-by":"publisher","DOI":"10.1177\/19714009251340319","author":"A Mortezaei","year":"2025","unstructured":"Mortezaei A, Emara M, Habibi MA et al (2025) Edaravone dexborneol for the treatment of acute ischemic stroke: a systematic review and meta-analysis. Neuroradiol J. https:\/\/doi.org\/10.1177\/19714009251340319","journal-title":"Neuroradiol J"},{"issue":"9","key":"5951_CR27","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s40263-019-00663-x","volume":"33","author":"DF Muresanu","year":"2019","unstructured":"Muresanu DF, Strilciuc S, Stan A (2019) Current drug treatment of acute ischemic stroke: challenges and opportunities. CNS Drugs 33(9):841\u2013847","journal-title":"CNS Drugs"},{"issue":"2","key":"5951_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00234-006-0183-z","volume":"49","author":"J Pan","year":"2007","unstructured":"Pan J, Konstas AA, Bateman B et al (2007) Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies. Neuroradiology 49(2):93\u2013102","journal-title":"Neuroradiology"},{"key":"5951_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1681859","volume":"16","author":"B Peng","year":"2025","unstructured":"Peng B, Wang R, Jiang W et al (2025) Edaravone dexborneol in acute ischemic stroke patients treated with combined intravenous thrombolysis and mechanical thrombectomy for large vessel occlusion. Front Neurol 16:1681859","journal-title":"Front Neurol"},{"issue":"12","key":"5951_CR30","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T et al (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke. Stroke 50(12):e344\u2013e418","journal-title":"Stroke"},{"issue":"8","key":"5951_CR31","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3109\/00207454.2014.959121","volume":"125","author":"Y Ren","year":"2015","unstructured":"Ren Y, Wei B, Song X et al (2015) Edaravone\u2019s free radical scavenging mechanisms of neuroprotection against cerebral ischemia: review of the literature. Int J Neurosci 125(8):555\u2013565","journal-title":"Int J Neurosci"},{"issue":"6","key":"5951_CR32","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1080\/00207454.2026.2628832","volume":"136","author":"H Sabet","year":"2026","unstructured":"Sabet H, Abbas A, Zanaty MA et al (2026) Evaluating the efficacy and safety of edaravone-dexborneol in acute ischemic stroke: an updated systematic review and meta-analysis of 7,846 Chinese patients. Int J Neurosci 136(6):767\u2013782","journal-title":"Int J Neurosci"},{"issue":"3","key":"5951_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/biom14030305","volume":"14","author":"MA Salaudeen","year":"2024","unstructured":"Salaudeen MA, Bello N, Danraka RN et al (2024) Understanding the pathophysiology of ischemic stroke: the basis of current therapies and opportunity for new ones. Biomolecules 14(3):305","journal-title":"Biomolecules"},{"issue":"12","key":"5951_CR34","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/jama.2016.13647","volume":"316","author":"JL Saver","year":"2016","unstructured":"Saver JL, Goyal M, van der Lugt A et al (2016) Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 316(12):1279\u20131288","journal-title":"JAMA"},{"issue":"12","key":"5951_CR35","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1161\/STROKEAHA.117.017283","volume":"48","author":"SI Savitz","year":"2017","unstructured":"Savitz SI, Baron JC, Yenari MA et al (2017) Reconsidering neuroprotection in the reperfusion era. Stroke 48(12):3413\u20133419","journal-title":"Stroke"},{"issue":"1","key":"5951_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/ds.DS-D-22-00154","volume":"41","author":"SC Shao","year":"2023","unstructured":"Shao SC, Kuo LT, Huang YT et al (2023) Using Grading of Recommendations Assessment, Development, and Evaluation (GRADE) to rate the certainty of evidence of study outcomes from systematic reviews: a quick tutorial. Dermatol Sin 41(1):3\u20137","journal-title":"Dermatol Sin"},{"key":"5951_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898","journal-title":"BMJ"},{"key":"5951_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-026-05439-x","author":"E Tariq","year":"2026","unstructured":"Tariq E, Ahmed H, Qazi TI et al (2026) Edaravone dexborneol in acute ischemic stroke: a systematic review and meta-analysis of randomized trials with clinical and thrombectomy-specific subgroup analyses. Naunyn-Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-026-05439-x","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"7","key":"5951_CR39","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S1474-4422(07)70170-9","volume":"6","author":"SE Vermeer","year":"2007","unstructured":"Vermeer SE, Longstreth WT, Koudstaal PJ (2007) Silent brain infarcts: a systematic review. Lancet Neurol 6(7):611\u2013619","journal-title":"Lancet Neurol"},{"key":"5951_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2025-086850","volume":"392","author":"C Wang","year":"2026","unstructured":"Wang C, Gu H, Huo X et al (2026) Edaravone dexborneol versus placebo on functional outcomes in patients with acute ischaemic stroke undergoing endovascular thrombectomy (TASTE-2): randomised controlled trial. BMJ 392:e086850","journal-title":"BMJ"},{"key":"5951_CR41","unstructured":"World Health Organization (n.d.) Stroke. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/stroke. Accessed 29 March 2026"},{"key":"5951_CR42","unstructured":"World Stroke Organization (n.d.) Impact of stroke. Available at: https:\/\/www.world-stroke.org\/world-stroke-day-campaign\/about-stroke\/impact-of-stroke. Accessed 29 March 2026"},{"key":"5951_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00028","volume":"13","author":"L Wu","year":"2020","unstructured":"Wu L, Xiong X, Wu X et al (2020) Targeting oxidative stress and inflammation to prevent ischemia-reperfusion injury. Front Mol Neurosci 13:28","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"5951_CR44","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1161\/STROKEAHA.120.031197","volume":"52","author":"J Xu","year":"2021","unstructured":"Xu J, Wang A, Meng X et al (2021) Edaravone dexborneol versus edaravone alone for the treatment of acute ischemic stroke: a phase III, randomized, double-blind, comparative trial. Stroke 52(3):772\u2013780","journal-title":"Stroke"},{"key":"5951_CR45","unstructured":"Zhou X, Shu ZG, Liu SC et al (2025) Effect of edaravone dexborneol combined with interventional thrombectomy on nerve function, cerebral hemodynamics, and serum levels of serum amyloid A, lipoprotein-associated phospholipase A2, and soluble CD40 ligand in elderly patients with ischemic stroke. J Physiol Pharmacol 76(1)"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05951-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05951-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05951-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:02:28Z","timestamp":1790262148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05951-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":45,"alternative-id":["5951"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05951-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"20 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required for this systematic review and meta-analysis.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informed consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that all data were generated in-house, that no paper mill was used and that no AI tool has been used for the generation of text or figures.","order":5,"name":"Ethics","label":"Declaration of AI","group":{"name":"EthicsHeading","label":"Declarations"}}]}}